Letter to the Editor January 16, 2006

Methodological Concerns Regarding the Relation Between Mefloquine and Serious Psychiatric Events in Females

Martin L. Tepper, MD, MHSc, FRCPC; Barbara A. Strauss, BScN, RN, MSc

J Clin Psychiatry 2006;67(1):164-164

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: van Riemsdijk et al.1 report the results of a case-control study of serious psychiatric events related to mefloquine use among Dutch travelers. A highlighted result is a (startling) odds ratio (OR) of 47.1 (with very wide 95% CI of 3.8 to 578.6) for such events in females taking mefloquine.

While the basic case-control methodology of this study appears sound, we have concerns that would erode confidence in this study: (1) The overall response rate from cases and controls is felt, by the authors, to be high enough ("almost 70%") to avoid selection bias.’ ‹